XML 54 R11.htm IDEA: XBRL DOCUMENT
v3.3.0.814

Commitments and Contingencies | 12 Months Ended
--- | ---
Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract] |
Commitments and Contingencies | Note 5 – Commitments and Contingencies Commitments and contingencies are described below and summarized by the following table as of June 30, 2014:
|  | Total |  |  | 2016 |  |  | 2017 |  |  | 2018 |  |  | 2019 |  |  | 2020 |  |  | Thereafter |
Management fee |  | $ | 1,800,000 |  |  | $ | 360,000 |  |  | $ | 360,000 |  |  | $ | 360,000 |  |  | $ | 360,000 |  |  | $ | 360,000 |  |  | $ | — |
ProstaScint Inventory Transfer |  |  | 500,000 |  |  |  | 500,000 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Sponsored research agreement with related party |  |  | 350,000 |  |  |  | 70,000 |  |  |  | 70,000 |  |  |  | 70,000 |  |  |  | 70,000 |  |  |  | 70,000 |  |  |  | — |
Clinical research and trial obligations |  |  | 329,000 |  |  |  | 329,000 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Manufacturing |  |  | 133,000 |  |  |  | 133,000 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Office Lease |  |  | 110,000 |  |  |  | 35,000 |  |  |  | 36,000 |  |  |  | 36,000 |  |  |  | 3,000 |  |  |  | — |  |  |  | — |
|  | $ | 3,222,000 |  |  | $ | 1,427,000 |  |  | $ | 466,000 |  |  | $ | 466,000 |  |  | $ | 433,000 |  |  | $ | 430,000 |  |  | $ | — |
Management Fee In July 2015, Aytu entered into agreements with Ampio whereby Aytu agreed to pay Ampio $30,000 per month for shared overhead which includes costs related to the shared facility, corporate staff, and other miscellaneous overhead expenses. These agreements will be in effect until they are terminated in writing by both parties. ProstaScint Inventory Transfer Fee Aytu is obligated to pay $500,000 for the ProstaScint-related product inventory upon the inventory transfer in July 2015. Sponsored Research Agreement with Related Party Aytu entered into a Sponsored Research Agreement with Trauma Research LLC (“TRLLC”), a related party, in June 2013. Under the terms of the Sponsored Research Agreement, TRLLC agreed to work collaboratively in advancing the RedoxSYS System diagnostic platform through research and development efforts. The Sponsored Research Agreement may be terminated without cause by either party on 30 days’ notice. Clinical Research and Trial Obligations In connection with the Zertane clinical trials and RedoxSYS research studies, the remaining commitment is $329,000. Aytu Manufacturing and Commercial Development Aytu entered into agreements with manufacturing companies to build its RedoxSYS system. The current remaining commitment is $133,000. Office Lease In June 2015, Aytu entered into a 37 month operating lease. This lease has initial base rent of $2,900 a month, with total base rent over the term of the lease of approximately $112,000. The Company recognizes rental expense of the facility on a straight-line basis over the term of the lease. Differences between the straight-line net expenses on rent payments are classified as liabilities between current deferred rent and long-term deferred rent. Rent expense for the respective periods is as follows:
|  | Years Ended June 30, |
|  | 2015 |  |  | 2014 |
Rent expense |  | $ | 51,000 |  |  | $ | 11,000 |

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for commitments and contingencies. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration